To ascertain the therapeutic potential of FoxO3 activity modulation by UCN‐01 in bona fide diseased lung fibroblasts, we performed corresponding studies in primary lung fibroblasts isolated from IPF patients, IPF‐HLF. Here, FOXO3 is linked to idiopathic pulmonary fibrosis.